Your browser doesn't support javascript.
loading
Thymosin-ß4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.
Cheung, Belamy B; Tan, Owen; Koach, Jessica; Liu, Bing; Shum, Michael S Y; Carter, Daniel R; Sutton, Selina; Po'uha, Sela T; Chesler, Louis; Haber, Michelle; Norris, Murray D; Kavallaris, Maria; Liu, Tao; O'Neill, Geraldine M; Marshall, Glenn M.
Affiliation
  • Cheung BB; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia. Electronic address: bcheung@ccia.unsw.edu.au.
  • Tan O; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Koach J; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Liu B; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Shum MS; Kids Research Institute, Children's Hospital at Westmead, Sydney, Australia.
  • Carter DR; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Sutton S; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Po'uha ST; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Chesler L; Division of Clinical Studies, Institute of Cancer Research, Sutton, Surrey, UK.
  • Haber M; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Norris MD; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Kavallaris M; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • Liu T; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia.
  • O'Neill GM; Kids Research Institute, Children's Hospital at Westmead, Sydney, Australia; Discipline of Paediatrics and Child Health, University of Sydney, Australia.
  • Marshall GM; Children's Cancer Institute Australia, University of New South Wales, Sydney, Australia; Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia. Electronic address: g.marshall@unsw.edu.au.
Mol Oncol ; 9(7): 1484-500, 2015 Aug.
Article in En | MEDLINE | ID: mdl-25963741
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymosin / Antineoplastic Combined Chemotherapy Protocols / Neuroblastoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thymosin / Antineoplastic Combined Chemotherapy Protocols / Neuroblastoma Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Mol Oncol Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2015 Document type: Article